Stock Market

Recent industry and macro factors caused Nvidia (NASDAQ:NVDA) stock to dip, sparking concerns about its 2023 rally. Despite a slight decline, don’t dismiss the ongoing generative AI mega trend driving its powerful performance.  That said, investors should recognize the limits of Nvidia’s growth potential despite the market’s enthusiasm for AI. While NVDA benefits from AI
0 Comments
Last week, meme investors “discovered” Rite Aid (NYSE:RAD), sending its shares up 70%. The Wall Street Journal would quickly give the company a meme stock crown. For most traditional investors, Rite Aid looks like a terrible bet. The struggling drug retailer hasn’t been profitable since 2017, and a deal five years ago to sell 1,932
0 Comments
Investors should expect a steep selloff among artificial intelligence stocks, as Wall Street cashes in on the high valuations many companies in this sector provide. On the other hand, some high-potential AI names remain overlooked, and the recent AI craze has done little to uplift their valuation. Thus, as the rally cools, smart investors will
0 Comments
While Upstart (NASDAQ:UPST) focuses on artificial intelligence in 2023, the company isn’t just jumping on the AI bandwagon. UPST stock earns a solid “B” grade because Upstart is deploying its technology in a useful and interesting way. Financial traders should weigh their tolerance for risk before considering an investment in Upstart. What Upstart seeks to achieve
0 Comments
In 2014, Massachusetts-based T2 Biosystems (NASDAQ:TTOO) went public at $11 per share. Expectations were high for the young startup. Its sepsis-detecting products targeted a $20.3 billion industry, and T2’s Magnetic Resonance Platform (T2MR) was potentially game-changing. Shares would quickly rise to a pre-split $23. The product, however, would prove a dud. In 2020, most of
0 Comments
The biotech industry proved itself resilient in the face of the COVID-19 pandemic. With research from Mckinsey, venture capitalist (VC) companies increased investments from 2,200 in 2016 to 3,100 in 2021 in biotechnology (biotech) startups. These startups have advanced medicine overall, improving cell therapy, tissue regeneration, genetic medicine, and more. With increasing innovation, we see
0 Comments
The International Energy Agency expects to see electric vehicle sales of around 14 million by the end of this year. Governments across the world are trying to increase EV popularity. National policies and incentives will likely help with sales.  The U.S. expects to deliver a 50% market share for electric cars by 2030. The European Union
0 Comments
The market’s strong rebound this year is driven by excitement over AI advancements, boosting major indexes. Nvidia (NASDAQ:NVDA) stock dropped 4.9%, Microsoft (NASDAQ:MSFT) fell 2.7%, and Alphabet (NASDAQ:GOOG) slipped 2.4%, partly due to credit rating agency Fitch downgrading the U.S. debt rating. Quarterly results of another AI-focused firm fell short of expectations, contributing to the
0 Comments
Artificial intelligence and data analytics are two of the most revolutionary technologies of our time, and at the heart of this revolution is Palantir Technologies (NYSE:PLTR). This software giant has carved out a significant slice of the market with its innovative data integration and AI-driven platforms, but is PLTR stock a wise investment choice after
0 Comments